Log In
BCIQ
Print this Print this
 

1265744 (GSK1265744) (formerly S-265744)

  Manage Alerts
Collapse Summary General Information
Company ViiV Healthcare Ltd.
DescriptionHIV integrase inhibitor
Molecular Target HIV integrase
Mechanism of ActionHIV integrase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today